AR101932A1 - Agente con propiedades antivirales para prevenir o tratar peces expuestos a un virus de la familia birnaviridae - Google Patents

Agente con propiedades antivirales para prevenir o tratar peces expuestos a un virus de la familia birnaviridae

Info

Publication number
AR101932A1
AR101932A1 ARP150102220A ARP150102220A AR101932A1 AR 101932 A1 AR101932 A1 AR 101932A1 AR P150102220 A ARP150102220 A AR P150102220A AR P150102220 A ARP150102220 A AR P150102220A AR 101932 A1 AR101932 A1 AR 101932A1
Authority
AR
Argentina
Prior art keywords
prophylactic
viruses
composition
agent
diseases caused
Prior art date
Application number
ARP150102220A
Other languages
English (en)
Spanish (es)
Inventor
Nilo Luis
Crdenas Constanza
Guzmn Fanny
Marshall Sergio
Original Assignee
Fundación Fraunhofer Chile Res
Pontificia Univ Católica De Valparaíso
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundación Fraunhofer Chile Res, Pontificia Univ Católica De Valparaíso filed Critical Fundación Fraunhofer Chile Res
Publication of AR101932A1 publication Critical patent/AR101932A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
ARP150102220A 2014-07-11 2015-07-13 Agente con propiedades antivirales para prevenir o tratar peces expuestos a un virus de la familia birnaviridae AR101932A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2014/063047 WO2016005796A1 (fr) 2014-07-11 2014-07-11 Agent avec des propriétés antivirales pour la prévention ou le traitement d'individus exposés à un virus de la famille des birnavirus

Publications (1)

Publication Number Publication Date
AR101932A1 true AR101932A1 (es) 2017-01-25

Family

ID=55063642

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150102220A AR101932A1 (es) 2014-07-11 2015-07-13 Agente con propiedades antivirales para prevenir o tratar peces expuestos a un virus de la familia birnaviridae

Country Status (5)

Country Link
EP (1) EP3166621A4 (fr)
AR (1) AR101932A1 (fr)
AU (1) AU2014400580A1 (fr)
CA (1) CA2954876A1 (fr)
WO (1) WO2016005796A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108129570B (zh) * 2017-12-25 2020-09-25 深圳市前海金卓生物技术有限公司 融合牛抗菌肽与白细胞介素2共表达重组酵母菌制剂的制备及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994004565A2 (fr) * 1992-08-26 1994-03-03 Proteus Molecular Design Limited Vaccin vnpi
WO2003013597A1 (fr) * 2001-08-10 2003-02-20 University Of Maryland Biotechnology Institute Vaccin sous-unite pour le virus de necrose pancreatique infectieux
US8221767B2 (en) * 2006-12-20 2012-07-17 Advanced Bionutrition Corporation Antigenicity of infectious pancreatic necrosis virus VP2 sub-viral particles expressed in yeast
WO2010111565A2 (fr) * 2009-03-27 2010-09-30 Advanced Bionutrition Corporation Vaccins microparticulaires utilisables pour procéder à une vaccination et à des rappels par voie orale ou nasale chez les animaux, dont les poissons
NO332608B1 (no) * 2011-03-16 2012-11-19 Norwegian School Of Veterinary Science Levende avirulent IPNV og vaksine for profylakse eller behandling av IPN-sykdom hos fisk
CN104884084B (zh) * 2012-09-26 2018-05-22 Fvg有限公司 鱼用亚单位浸泡疫苗

Also Published As

Publication number Publication date
CA2954876A1 (fr) 2016-01-14
AU2014400580A1 (en) 2017-02-16
WO2016005796A1 (fr) 2016-01-14
EP3166621A4 (fr) 2018-05-09
EP3166621A1 (fr) 2017-05-17

Similar Documents

Publication Publication Date Title
MX2018014573A (es) Vacuna contra el virus del zika.
MX2016012938A (es) Composiciones estables de yodo no en complejo y metodos de uso.
CL2019000732A1 (es) Tratamiento avv de la enfermedad de huntington.
BR112017011923A2 (pt) bactéria modificada para tratar doenças associadas com hiperamonemia
EP4631970A3 (fr) Molécules d'acide nucléique et leurs utilisations
CO2019009215A2 (es) Sal hemi-sulfato de nucleótido para el tratamiento del virus de la hepatitis c
EP4691484A3 (fr) Vaccins contre l'arnm de la grippe
MX2017015938A (es) Inhibidores de ezh2 para el tratar linfomas.
PH12015502230A1 (en) Novel viral replication inhibitors
EA201792429A1 (ru) Производные моно- или дизамещенных индолов в качестве ингибиторов репликации вирусов денге
NI201800039A (es) Derivados de indol mono- o disustituidos como inhibidores de la replicación viral del dengue
NI201800040A (es) Derivados de indol mono- o disustituidos como inhibidores de la replicación viral del dengue
CO2018010874A2 (es) Vacuna de virus de zika atenuado vivo
MX2016012799A (es) Metodos para tratar el virus de la hepatitis c.
EA201791614A1 (ru) Производные индола в качестве ингибиторов репликации вирусов денге
AR112166A1 (es) Composiciones terapéuticas y métodos para el tratamiento de hepatitis b
MX383330B (es) Particula tipo virus de flavivirus.
MX388251B (es) Nuevo anticuerpo que se una a tfpi y composicion que comprende el mismo.
EA201692111A1 (ru) Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний
MX2018004796A (es) Conservacion de vitaminas hidrosolubles.
CL2018001946A1 (es) Virus atenuados de bronquitis infecciosa.
MX391376B (es) Composiciones de la membrana de la cáscara del huevo para usarse en el tratamiento de la cadena ligera kappa del factor nuclear de las células b activadas (nf-kb) en un organismo hospedero.
AR101932A1 (es) Agente con propiedades antivirales para prevenir o tratar peces expuestos a un virus de la familia birnaviridae
EA201790776A1 (ru) Комбинированные композиции длительного действия и способы лечения гепатита с
EA201790771A1 (ru) Фармацевтические композиции длительного действия для лечения гепатита c

Legal Events

Date Code Title Description
FB Suspension of granting procedure